As expected, the growth of wild type (wt) p53 MCF7 breast carcinoma cells was suppressed by Nutlin-3 treatment, whereas it had no effect in p53-depleted (KO) cells, in line with the notion that Nutlin-3 induces cell cycle arrest and/or apoptosis specifically through p53 activation. This evidence concerns the gene TP53 and breast carcinoma.